Eisler Capital (Uk) Ltd. Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Eisler Capital (Uk) Ltd.

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $1.4 Million - $1.65 Million	1,371 Added 19.46%	8,418 $8.85 Million
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $1.64 Million - $1.98 Million	1,853 Added 35.68%	7,047 $7.41 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $1.8 Million - $1.98 Million	1,998 Added 62.52%	5,194 $5 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $1.95 Million - $2.21 Million	2,510 Added 365.89%	3,196 $2.81 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $475,020 - $579,237	686 New	686 $564,000

1,535

83.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.